Depomed, Inc. – Strategy and SWOT Report – Market Research Report

Depomed, Inc. – Strategy and SWOT Report, is a source of comprehensive company data and information.

A announce a new report through its vast collection of market research report :

Depomed, Inc. – Strategy and SWOT Report – Market Research Report

For some-more information, Great fully visit:

Depomed, Inc. – Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

– Detailed information on Depomed, Inc. required for business and competitor intelligence needs – A study of the major internal and external factors affecting Depomed, Inc. in the form of a SWOT analysis – An in-depth view of the business model of Depomed, Inc. including a breakdown and examination of key business segments – Intelligence on Depomed, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors – News about Depomed, Inc., such as business expansion, restructuring, and contract wins – Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Depomed is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. The company primarily operates in the US. Depomed is headquartered in Menlo Park, California and employed 70 people as of December 31, 2010. The company recorded revenues of $80.8 million during the financial year (FY) ended December 2010, an increase of 39.9% over FY2009. The operating profit of the company was $3.6 million during FY2010, as compared to an operating loss of $22.1 million in FY2009. The net profit was $3.9 million in FY2010, as compared to a net loss of $22 million in FY2009.

Reasons to Purchase:

– Gain understanding of Depomed, Inc. and the factors that influence its strategies – Track strategic initiatives of the company and latest corporate news and actions – Assess Depomed, Inc. as a prospective partner, vendor or supplier – Support sales activities by understanding your customers businesses better – Stay up to date on Depomed, Inc.’s business structure, strategy and prospects     

Table of Contents :

Company Snapshot Depomed, Inc.: Company Overview Depomed, Inc.: Overview and Key Facts Depomed, Inc.: Overview Depomed, Inc.: Key Facts Depomed, Inc.: Key Employees Depomed, Inc.: Key Employee Biographies Depomed, Inc.: Major Products and Services Depomed, Inc.: Company History Depomed, Inc.: Management Statement Depomed, Inc.: Key Competitors Depomed, Inc.: Company Analysis Depomed, Inc.: Business Description Depomed, Inc.: SWOT Analysis Depomed, Inc.: SWOT Overview Depomed, Inc.: Strengths Depomed, Inc.: Weaknesses Depomed, Inc.: Opportunities Depomed, Inc.: Threats Depomed, Inc.: Corporate Financial Deals Activity Depomed, Inc.: Financial Deals Overview Depomed, Inc.: Targets and Partners Depomed, Inc.: Top Deals 2007 -YTD*2011 Depomed, Inc.: Partnership Depomed, Inc.: Recent Developments Depomed, Inc.: News and Events Summary Depomed, Inc.: Business Expansion Depomed, Inc.: Contracts Depomed, Inc.: Corporate Governance Depomed, Inc.: Financial Deals Depomed, Inc.: Financial Performance Depomed, Inc.: Grants Depomed, Inc.: Regulatory and Legal Events Depomed, Inc.: Research & Development Depomed, Inc.: Strategy and Operations Appendix Contact Us Methodology Definitions About Datamonitor

List of Tables

Table 1: Depomed, Inc.: Key Facts Table 2: Depomed, Inc.: Key Employees Table 3: Depomed, Inc.: Key Competitors Table 4: Depomed, Inc.: Deal Activity by Deal Type – Volume (TTM) Table 5: Depomed, Inc.: Deal Activity by Deal Type – Volume (2007 – YTD*2011) Table 6: Depomed, Inc.: Targets and Partners Table 7: Depomed, Inc.: Top Deals 2007 -YTD*2011 Table 8: Depomed, Inc.: Partnership Volume and Value Trend (2007 – YTD*2011) Table 9: Depomed, Inc.: Partnership Trend by Deal Type (2007 – YTD*2011) Table 10: Depomed, Inc.: News and Events Summary Table 11: Depomed, Inc.: Business Expansion Table 12: Depomed, Inc.: Contracts Table 13: Depomed, Inc.: Corporate Governance Table 14: Depomed, Inc.: Financial Deals Table 15: Depomed, Inc.: Financial Performance Table 16: Depomed, Inc.: Grants Table 17: Depomed, Inc.: Regulatory and Legal Events Table 18: Depomed, Inc.: Research & Development Table 19: Depomed, Inc.: Strategy and Operations

List of Figures

Figure 1: Depomed, Inc.: Deal Activity by Deal Type – Volume (TTM) Figure 2: Depomed, Inc.: Deal Activity by Deal Type – Volume (2007 – YTD*2011) Figure 3: Depomed, Inc.: Partnership Volume and Value Trend (2007 – YTD*2011) Figure 4: Depomed, Inc.: Partnership Trend by Deal Type (2007 – YTD*2011)

Related Pharmaceuticals and Healthcare report:

BioMarin Pharmaceutical Inc. – Strategy and SWOT Report

Boehringer Ingelheim GmbH – Strategy and SWOT Report